Cargando…

COVID-19 vaccine trials should seek worthwhile efficacy

Detalles Bibliográficos
Autores principales:	Krause, Philip, Fleming, Thomas R, Longini, Ira, Henao-Restrepo, Ana Maria, Peto, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization. Published by Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832749/ https://www.ncbi.nlm.nih.gov/pubmed/32861315 http://dx.doi.org/10.1016/S0140-6736(20)31821-3

Ejemplares similares

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

COVID-19 vaccine trials: The use of active controls and non-inferiority studies
por: Fleming, Thomas R, et al.
Publicado: (2021)

The fight against cancer: Is it worthwhile?
por: Barreto, Savio George, et al.
Publicado: (2015)

Epidemiology, not geopolitics, should guide COVID-19 vaccine donations
por: Bollyky, Thomas J, et al.
Publicado: (2021)

Considerations in boosting COVID-19 vaccine immune responses
por: Krause, Philip R, et al.
Publicado: (2021)

Safety of COVID-19 vaccines: who should see an allergist
Publicado: (2021)

Covid-19 vaccine apps should deliver more to patients
por: Dasgupta, Nabarun, et al.
Publicado: (2021)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Haemoperfusion should only be used for COVID-19 in the context of randomized trials
por: Clark, Edward G., et al.
Publicado: (2020)

An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool
por: Bellan, Steven E., et al.
Publicado: (2019)

Mandatory Flu Vaccine for Healthcare Workers: Not Worthwhile
por: Edmond, Michael B
Publicado: (2019)

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era
por: Franco-Paredes, Carlos, et al.
Publicado: (2022)

Be the change you seek in science
por: Milham, Michael P., et al.
Publicado: (2019)

Canada 2010: what should global health expect?
por: Horton, Richard
Publicado: (2009)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

COVID-19: when should quarantine be enforced?
por: Bauch, Chris T, et al.
Publicado: (2020)

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
por: Longini, Ira M, et al.
Publicado: (2022)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
por: Reuben, Rine Christopher, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

Blinding in trials of interventional procedures is possible and worthwhile
por: Wartolowska, Karolina, et al.
Publicado: (2018)

Seeking Common Ground in Nuclear Complexity
por: Shopland, Lindsay S., et al.
Publicado: (2000)

Seek and ye shall maybe find
por: Petsko, Gregory A
Publicado: (2000)

Should COVID-19 take advice from rheumatologists?
por: Kernan, Kate F, et al.
Publicado: (2020)

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
por: Olliaro, Piero, et al.
Publicado: (2021)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

Vaccination under TNF blockade - less effective, but worthwhile
por: Aringer, Martin
Publicado: (2012)

When failure should be the option
por: Petsko, Gregory A
Publicado: (2010)

Should UK Pneumococcal Vaccine Eligibility Criteria Include Alcohol Dependency in Areas with High Alcohol-Related Mortality?
por: Mooney, John D., et al.
Publicado: (2018)

SARS: seeking a real-time solution
Publicado: (2013)

Local distribution infrastructure and robust vaccine manufacturing facilities in LMICs should be prioritised to tackle ongoing and future pandemic risk
por: Reza, Hasan Mahmud, et al.
Publicado: (2023)

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine
por: Kennedy, Richard B
Publicado: (2022)

Violence against women in the Philippines: barriers to seeking support
por: Valdez, Isabel Kristine M., et al.
Publicado: (2022)

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
por: Wang, Tao, et al.
Publicado: (2020)

Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines
por: Jiang, Hu-Dachuan, et al.
Publicado: (2021)

Tocilizumab in COVID-19: Is the Temptation Worthwhile?
por: Gupta, Sachin, et al.
Publicado: (2021)

GPs should not try to detect mild COPD
por: Enright, Paul, et al.
Publicado: (2020)

When and which patients should receive remdesivir?
por: Garcia-Vidal, Carolina, et al.
Publicado: (2022)

Should we splint traumatised primary teeth?
por: Deery, Chris
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vv404uqhuif1jabsrrnirc48fp